"Redundancy" of endocannabinoid inactivation: new challenges and opportunities for pain control
about
Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain ManagementThe endocannabinoid system as a potential therapeutic target for pain modulationElevating endocannabinoid levels: pharmacological strategies and potential therapeutic applicationsRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationSelective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents.Celastrol attenuates inflammatory and neuropathic pain mediated by cannabinoid receptor type 2.Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake.Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates.Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.Modulating the endocannabinoid system in human health and disease--successes and failuresImplication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6.Spatial Distribution of the Cannabinoid Type 1 and Capsaicin Receptors May Contribute to the Complexity of Their Crosstalk.PUFA-derived endocannabinoids: an overview.Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics.Anandamide in primary sensory neurons: too much of a good thing?Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.A systems pharmacology perspective on the clinical development of Fatty Acid amide hydrolase inhibitors for pain.Targeting the endogenous cannabinoid system to treat neuropathic pain.N-acylethanolamine acid amidase (NAAA), a new path to unleash PPAR-mediated analgesia.The Endocannabinoid System: From Basic Research toTranslational Opportunity.The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in Osteoarthritis.Harnessing the pyrroloquinoxaline scaffold for FAAH and MAGL interaction: definition of the structural determinants for enzyme inhibition
P2860
Q28067493-B2A51FED-457D-45BF-97C9-C521BA74FF38Q28247621-6EB1390B-E9AC-42F7-AE55-2A5ACE18DD8AQ28300390-B2CD420C-6A5F-4349-9B8E-1289AE42493DQ30357558-8E479F8F-5BC7-4E2D-AADC-0F7E1745B063Q30612936-28AF6F88-3DA8-4ED7-9019-220364FFC1B1Q34158418-D3CF5866-CFAE-4F56-9442-633F039C6B1CQ34557589-905CEF76-45D7-418D-B46D-F9E336570DCAQ34644485-8292620B-2AA6-428F-B98C-3F41809267ACQ36576347-CF44B730-C1BF-4C68-AC1A-A282E2AD7DC2Q36823364-D54E9BF5-05B5-4D11-A040-2C40D9082B58Q36933683-2A3A3BCE-D2E8-4E7D-926F-B32ACB22364BQ37256080-50A86BB5-5E92-4738-BBEA-A3B477469269Q37274198-C5DEF881-6D2C-4B7C-A882-1A60ADB2F71DQ38135917-5393F035-F892-4EFF-A45F-8268D06160A0Q38166804-4561DE5E-357B-4D99-9490-99DC61BC9805Q38185073-5B936D3E-7FCB-4AE5-A5A9-31EAFDFDB6F2Q38212376-50B605A7-48FA-4E1D-B247-2F3D0BA50779Q39271494-8C5A34FE-3A81-4CED-A86C-DDB2B3B6CE18Q41990169-BF94E991-699A-4AD6-A941-91E263C12B86Q42657017-FDC1FDA0-3B59-4440-96BC-1E15018AFCB0Q46112621-A0D09532-29C8-4962-BAB2-49E8C429588DQ47159533-DCACD63F-15AE-4E62-AD9A-BA1FCCBB4093Q49827867-7A10EDCB-4B7C-4A1E-86E1-09A0DBEF8C8EQ58855638-8479DDFE-B301-4AD3-B94C-4033A57099B1
P2860
"Redundancy" of endocannabinoid inactivation: new challenges and opportunities for pain control
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
"Redundancy" of endocannabinoi ...... opportunities for pain control
@ast
"Redundancy" of endocannabinoi ...... opportunities for pain control
@en
"Redundancy" of endocannabinoi ...... opportunities for pain control
@nl
type
label
"Redundancy" of endocannabinoi ...... opportunities for pain control
@ast
"Redundancy" of endocannabinoi ...... opportunities for pain control
@en
"Redundancy" of endocannabinoi ...... opportunities for pain control
@nl
prefLabel
"Redundancy" of endocannabinoi ...... opportunities for pain control
@ast
"Redundancy" of endocannabinoi ...... opportunities for pain control
@en
"Redundancy" of endocannabinoi ...... opportunities for pain control
@nl
P2860
P3181
P356
P1476
"Redundancy" of endocannabinoi ...... opportunities for pain control
@en
P2860
P304
P3181
P356
10.1021/CN300015X
P407
P577
2012-05-16T00:00:00Z